SPI
18.219,49
PKT
+34,44
PKT
+0,19
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.03.12 | Partners Group neutral | Sarasin Research | |
| 14.03.12 | Avolta (ex Dufry) buy | Sarasin Research | |
| 14.03.12 | Avolta (ex Dufry) buy | ING | |
| 13.03.12 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 13.03.12 | Galenica neutral | Sarasin Research | |
| 13.03.12 | BELIMO neutral | UBS AG | |
| 13.03.12 | ARYZTA buy | UBS AG | |
| 12.03.12 | Nestlé hold | ING | |
| 12.03.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.03.12 | ARYZTA neutral | Sarasin Research | |
| 09.03.12 | Holcim neutral | Sarasin Research | |
| 09.03.12 | UBS neutral | WestLB AG | |
| 09.03.12 | Novartis buy | UBS AG | |
| 08.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 08.03.12 | UBS buy | Citigroup Corp. | |
| 08.03.12 | Tecan (N) neutral | Sarasin Research | |
| 08.03.12 | Geberit neutral | Sarasin Research | |
| 08.03.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 08.03.12 | OC Oerlikon buy | UBS AG | |
| 08.03.12 | GAM buy | UBS AG | |
| 07.03.12 | Kühne + Nagel International neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Swiss Life neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 07.03.12 | GAM neutral | Credit Suisse Group | |
| 06.03.12 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 06.03.12 | Holcim buy | UBS AG | |
| 06.03.12 | Mobimo buy | Sarasin Research | |
| 06.03.12 | GAM neutral | Sarasin Research | |
| 06.03.12 | Arbonia buy | Sarasin Research | |
| 06.03.12 | Swiss Life buy | Sarasin Research | |
| 05.03.12 | Sulzer buy | Sarasin Research | |
| 05.03.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 05.03.12 | dormakaba neutral | Sarasin Research | |
| 02.03.12 | Swatch (I) buy | Sarasin Research | |
| 01.03.12 | Sika neutral | Sarasin Research | |
| 01.03.12 | Lindt neutral | Sarasin Research | |
| 01.03.12 | Adecco SA buy | Sarasin Research | |
| 01.03.12 | OC Oerlikon buy | UBS AG | |
| 01.03.12 | Holcim neutral | Credit Suisse Group |